Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. And Roche Molecular Systems, Inc.

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. and its parent company, Roche Molecular Systems, Inc. Illumina is seeking all available remedies.

The new suit, filed in the U.S. District Court for the Northern District of California, is based on Ariosa’s infringement of U.S. Patent No. 7,955,794 (the ‘794 patent), entitled “Multiplex Nucleic Acid Reactions.” The suit is focused on Ariosa’s Microarray-based version of its Harmony™ Prenatal Test.

Help employers find you! Check out all the jobs and post your resume.

Back to news